Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BDCZ vs PHYL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PHYL Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)

PHYL Overall Winner 6-Pillar Tally: BDCZ 0 – 0 PHYL (6 Tie) Matrix Metrics: BDCZ 2 – 1 PHYL

As of Nov 20, 2026, PGIM Active High Yield Bond ETF (PHYL) is the stronger overall head-to-head candidate over ETRACS MarketVector Business Development Companies Liquid Index ETN due April 26, 2041 (BDCZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BDCZ carries a Unified Composite Score of 48.1/100 (HOLD) at $13.70 (N/M Forward P/E, N/A operating margin), whereas PHYL carries 42.3/100 (HOLD) at $33.20 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While BDCZ currently prints a higher short-term Unified Composite Score (48.1/100 HOLD vs. PHYL 42.3/100 HOLD), PHYL captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: BDCZ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.2); meanwhile PHYL is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 32.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BDCZ vs PHYL
BDCZ NYSE Arca
ETRACS MarketVector Business Development Companies Liquid Index ETN due April 26, 2041
Institutional Equity
$13.70
-1.14% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.41β · 20% Vol
Unified Composite Score
48.1 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 34
RSI-14: 34.2 · SMA20: $14.31 · SMA50: $14.47
PHYL NYSE Arca Head-to-Head Winner
PGIM Active High Yield Bond ETF
Institutional Equity
$33.20
-0.18% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.17β · 5% Vol
Unified Composite Score
42.3 / 100 HOLD
Tech 31.0 Fund 50.0 Flow 50.0 Mom 74.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.3%) with fading momentum, RSI 33
RSI-14: 32.7 · SMA20: $33.54 · SMA50: $33.67

6-Pillar Scorecard Institutional Category Breakdown (BDCZ 0 – 0 PHYL)

Columns: Metric · BDCZ · PHYL
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BDCZ (2) vs PHYL (1)
Institutional Metric BDCZ PHYL Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
18% ($13–$17) 1% ($33–$36) Stronger Trend BDCZ
Beta / 30D Volatility
Risk Regime
0.41β · 20% Vol 0.17β · 5% Vol Lower Realized Risk PHYL
Unified Institutional Score
Composite Signal
48.1 / 100 (HOLD) 42.3 / 100 (HOLD) Higher Composite BDCZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BDCZ +0.89 pp
BDCZ: -0.18% · PHYL: -1.07%
3M Horizon PHYL +6.97 pp
BDCZ: -11.6% · PHYL: -4.63%
6M Horizon PHYL +1.62 pp
BDCZ: -7.03% · PHYL: -5.41%
1Y Horizon PHYL +9.1 pp
BDCZ: -14.8% · PHYL: -5.7%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDCZ vs PHYL. Trailing 12-month operating profitability (BDCZ N/A vs PHYL N/A) and valuation multiples (BDCZ N/M vs PHYL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BDCZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PHYL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BDCZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BDCZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PHYL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PHYL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BDCZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PHYL Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BDCZ vs PHYL Key Questions & Quantitative Answers

As of Nov 20, 2026, PGIM Active High Yield Bond ETF (PHYL) is the stronger overall head-to-head candidate over ETRACS MarketVector Business Development Companies Liquid Index ETN due April 26, 2041 (BDCZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BDCZ carries a Unified Composite Score of 48.1/100 (HOLD) at $13.70 (N/M Forward P/E, N/A operating margin), whereas PHYL carries 42.3/100 (HOLD) at $33.20 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While BDCZ currently prints a higher short-term Unified Composite Score (48.1/100 HOLD vs. PHYL 42.3/100 HOLD), PHYL captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: BDCZ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.2); meanwhile PHYL is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 32.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BDCZ and PHYL split Growth & Scale metrics: BDCZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PHYL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BDCZ generates N/A in USD-normalized revenue versus N/A for PHYL. In operating R&D and SG&A reinvestment, BDCZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PHYL.

BDCZ and PHYL trade at balanced relative valuation multiples. BDCZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PHYL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BDCZ (N/A ROE) versus PHYL (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, BDCZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.41β · 20% Vol realized risk). By comparison, PHYL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.17β · 5% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.